MONTRÉAL, Dec. 4 /CNW/ - Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), an innovative leader of on-line marketing services to physicians, today announced the appointment of Mr. Robert Steinfeld to the Corporation's board of directors.
Robert H. Steinfeld, LL.M., J.D., served as Senior Vice President, General Counsel and Corporate Secretary of IMS Health Inc. from 2000 to 2009. He joined Cognizant Corporation in February, 1997 as Director of Taxes. He played a key role in the structuring of the IMS-Gartner Group spin-off and also in the Synavant spin-off. From September 1993 to February, 1997, Mr. Steinfeld served as Vice President, Taxation at Ultramar Corporation. Mr. Steinfeld earned a BA from Columbia University in 1975, a JD from the Columbia University School of Law in 1978, and an LLM in Taxation from the New York University School of Law in 1981.
The Corporation's board of directors is now comprised of Roger Korman, Chairman & CEO, Denis Martineau, President, Mark Benthin, COO, Justin Beckett, Robert Boisjoli, Tommy Boman, André Brosseau and Robert Steinfeld.
Aptilon has also granted a total of 7,580,000 stock options, of which 6,200,000 were issued to directors and officers. Each option is valid for five years, is exercisable at a price of $0.105. One-twelfth of the options granted vest on each quarterly anniversary of date of the grant over a total period of three years.
Aptilon also announces that further to its acquisition of the assets of Direct Medical Data, LLC ("DMD") and BLM Incorporated announced on September 18, 2009, DMD's three partners, Norman E. Swanson, Louis D. Dixon and Robert J. Sbarbaro, have been named directors of DMD Marketing Corp., a wholly-owned subsidiary of an affiliate of Aptilon. In addition, Mr. Sbarbaro has been appointed Senior Vice-President, Sales of DMD Marketing Corp.
About Aptilon Corporation
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach and interact with physicians and healthcare professionals via the Internet through its innovative AxcelRx(SM) service, ReachNet(SM) healthcare professional access network and licensed access to over sixty professional databases. Top US pharmaceutical and healthcare companies have adopted Aptilon's solutions to improve their sales and marketing efforts to reach leading physicians and allied healthcare professionals on-line. Aptilon provides the necessary infrastructure for companies to build physician awareness, understanding, and product preference during all stages of a product's life cycle; from pre-launch education through end stage support. For more information, visit www.aptilon.com.
AxcelRx(SM) and ReachNet(SM) are service marks of Aptilon Corporation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE DMD Digital Health Connections Group Inc.
For further information: For further information: Denis Martineau, President, Aptilon Corporation, 1-888-544-8866, email@example.com; Ross Marshall, Investor Relations, The Equicom Group, (416) 815-0700 x 238, firstname.lastname@example.org